Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.116NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.134NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.393NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.381NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
C.32NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AE.8NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.516NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.526NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.279NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AE.7NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
N.6NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.36NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.407NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-4751.81US
B.20NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.423NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.281NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AE.6NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.230NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.535NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
A.7NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
A.24NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.564.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.345NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.53NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-4751.81US
B.1.1.450NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.334NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-18756.6US
B.1.589NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.335NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.169NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.43NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.42NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AE.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.442NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.75NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.51NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.106NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
D.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.593NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.438.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-20190.6US
B.1.1.290NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.341NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.161NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.69 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.46NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.139NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.508NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.94NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.463NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-4751.81US
B.1.357NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.318NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used